Phibro Animal Health reported fiscal 2026 net sales of $1.52 billion, up 17%, while adjusted EBITDA climbed 39% to $255 million. The company expects continued growth in fiscal 2027 while planning to consolidate its manufacturing network.
The National Association of Veterinary Technicians in America is accepting nominations for its 2026 Veterinary Technician of the Year Award, recognizing a credentialed veterinary technician for professional excellence, leadership and contributions to the profession. Nominations are due Nov. 6, 2026, at noon EST.
Ignite Veterinary Solutions has launched Unlimited, a practice-wide training and resource platform designed to give veterinary support teams access to on-demand answers, educational programs and ready-to-use workplace tools. The platform includes an AI-powered learning assistant that draws from Ignite’s veterinary-specific content rather than the open internet.
Elanco Animal Health has completed a 25,000-square-foot expansion of its Elwood, Kansas, manufacturing facility, increasing production capacity by more than four times as the company scales its monoclonal antibody portfolio. Elanco has invested $120 million in the project and plans another $30 million through 2028.
Global veterinary antibiotic sales are forecast to reach $6.36 billion by 2031, with livestock disease, companion animal spending and aquaculture supporting demand even as antimicrobial resistance policies reshape prescribing and product development.
Zoetis has received an FDA Emergency Use Authorization for Simparica Trio to treat New World screwworm infestations in dogs and puppies, expanding the animal health company’s response to the emerging parasite threat across companion animals and livestock.
JustFoodForDogs has expanded its prescription Veterinary Support Diet portfolio with a new low-fat Digestive Care recipe and an updated Metabolic + Weight Control formula designed to support dogs with specific nutritional needs.
Wolters Kluwer Health has launched Medi-Span Vet Meds, a veterinary drug data and screening solution designed to help retail pharmacies and medication fulfillment providers dispense prescriptions for pets. A company survey found 75% of U.S. pet owners surveyed would like to obtain pet prescriptions through the same channels they use for family medications.
IDEXX Laboratories is expanding its Catalyst diagnostic platform with Catalyst proBNP, a quantitative in-clinic NT-proBNP test for cats and dogs. The test is designed to help veterinarians screen for, evaluate and monitor cardiac disease while providing results during the patient visit.
Zoetis reported second-quarter 2026 revenue of $2.5 billion, flat year over year on a reported basis, as weaker U.S. companion animal demand weighed on results. The animal health company also lowered its full-year revenue, adjusted net income and adjusted EPS guidance.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.